Historical perspectives on autism: Its past record of discovery and its present state of solipsism, skepticism, and sorrowful suspicion

Pediatric Clinics of North America

Volumn 59, Issue 1, 2012, Pages 1-11

  Greydanus, Donald E ^a   Toledo Pereyra, Luis H ^a,b,c  

^a Michigan State University Kalamazoo Center for Medical Studies   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Autism; History; Media effects; Vaccine controversy

Indexed keywords

ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; ATTITUDE TO DISABILITY; AUTISM; BEHAVIORAL SCIENCE; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENTEROCOLITIS; EPILEPSY; HEALTH CARE; HUMAN; INFANTILE AUTISM; LAW ENFORCEMENT; LEARNING DISORDER; MASS IMMUNIZATION; MEDICAL RESEARCH; MENTAL DEFICIENCY; NONHUMAN; PROFESSIONAL KNOWLEDGE; RELIGION; REVIEW; SCHIZOPHRENIA;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; INFANT; INFANT, NEWBORN; VACCINATION;

EID: 84856247409     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.10.004     Document Type: Review

References (66)

1. King A. Adolescence. Child and adolescent psychiatry. A comprehensive textbook 2002, 332-342. Lippincott Williams & Wilkins, Philadelphia, Chapter 24. 3rd edition. M. Lewis (Ed.).
2. Greydanus D.E., Pratt H.D. Syndromes and disorders associated with mental retardation: selected comments. Indian J Pediatr 2005, 72(10):27-32.
3. Beck S. Prehistoric cultures. Mideast and Africa to 1700 2000, 648. World Peace Communications, Santa Barbara (CA). S. Beck (Ed.).
4. Greydanus D.E., Van Dyke D. Epilepsy in the adolescent: the sacred disease and the clinician's sacred duty. Int Pediatr 2005, 20(2):6-8.
5. Su H., Van Dyke D.C. Breaking the silence and overcoming the invisibility: Down syndrome in China. Int Pediatr 2005, 20(1):25-33.
6. Mackelprang R.W., Salsgiver R.O. Disability: a diversity model approach in human service practice 1998, Cengage Learning, Florence (KY), p. 270.
7. Sulkes S.B. MR in children and adolescent. Behavioral Pediatrics 2006, 66-83. Universe, Inc, New York (NY), [Chapter: 3]. D.E. Greydanus, H.D. Pratt, D.R. Patel (Eds.).
8. Wing L. The history of ideas on autism: legends, myths, and reality. Autism 1997, 1:13-27.
9. Houston R., Frith U. Autism in history: the case of Hugh Blair of Borgue 2000, Blackwell, London (England).
10. Wolff S. The history of autism. Eur Child Adolesc Psychiatry 2004, 13:201-208.
11. Wolrich M. Mental retardation. Behavioral pediatrics 1992, 314-323. Springer-Verlag, New York, [Chapter: 22]. D.E. Greydanus, M.L. Wolrich (Eds.).
12. Wolfensberger W. The extermination of handicapped people in World War II Germany. Ment Retard 1981, 19:1-7.
13. Greydanus D.E., Bhave S. Adolescents with mental retardation. Recent Adv Pediatr 2006, 17:174-192.
14. Huygelen C. Verh K Acad Geneeskd Belg 1996, 58:479-536. [in Dutch].
15. Tafuri S., Martinelli D., Prato R., et al. Ann Ig 2011, 23:93-99. [in Italian].
16. Fichman M., Keelan J.E. Register's logic: the anti-vaccination arguments of Alfred Russel Wallace and their role in the debates over compulsory vaccination in England, 1870-1907. Stud Hist Philos Biol Biomed Sci 2007, 38:585-607.
17. Bleuler Eugen P. Lehrbuch der psychiatrie [textbook of psychiatry] 1983, Springer, Berlin (Germany), (original 1916). ISBN 3540118330.
18. Hell D., Scharfetter C., Möller A. Eugen Bleuler, Leben und Werk 2001, Huber, Bern (Switzerland), ISBN 3456836465.
19. Bender L. In memoriam. Leo Kanner MD June 13, 1894-April 4, 1981. JAm Acad Child Psychiatry 1982, 21:88-89.
20. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943, 2:217-250.
21. Kanner L. Irrelevant and metaphorical language in early infantile autism. Am J Psychiatry 1946, 103:242-246. 13.
22. Kanner L., Eisenberg L. Early infantile autism 1943-1955. Am J Orthopsychiatry 1956, 26:55-66.
23. Asperger H. 1944 "Autistic psychopathy" in childhood. Autism and Asperger syndrome 1991, 37-92. (Translated and annotated by Frith U (1991), Cambridge University Press, Cambridge (United Kingdom). U. Frith (Ed.).
24. Asperger H. Med Klin 1974, 69:2024-2027. [in German].
25. Wing L. Asperger's syndrome: a clinical account. Psychol Med 1981, 11:115-129.
26. Asperger H. Pediatr Padol 1977, 12:214-233. [in German].
27. Lyons V., Fitzgerald M. Did Hans Asperger (1906-1980) have Asperger syndrome?. JAutism Dev Disord 2007, 37:2020-2021.
28. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, (DSM-IV), American Psychiatric Association, Washington, DC. 4th edition.
29. Severson K.D., Aune J.A., Jodlowski D. Bruno Bettleheim, autism, and the rhetoric of scientific authority. Autism and representation. Routledge research in cultural and media studies 2007, 65-77. Routledge, London (England). M. Osteen (Ed.).
30. Pollack R. The creation of Dr. B: a biography of Bruno Bettelheim 1997, Simon & Schuster, New York, p. 478.
31. Bettelheim B. Joey: a "mechanical boy." Sci Am 1959, 200:116-120.
32. Bettelheim B. The empty fortress: infantile autism and the birth of the self 1967, The Free Press: Simon & Schuster, New York, p. 484.
33. Osgood N.J. Suicide in later life 1992, Lexington Books, New York (NY), p. 4.
34. Park C.C. The siege: the first eight years of an autistic child 1967, Little, Brown and Company, Boston.
35. Rimland B. Infantile autism: the syndrome and its implications for a neural theory of behavior 1964, Appleton-Century-Crofts, New York.
36. DeStefano F., Chen R.T. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. JPediatr 2000, 136:125-126.
37. Mrozek-Budzyn D., Kieltyka A., Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J 2010, 29:397-400.
38. Institute of Medicine. Adverse effects of vaccines: evidence and causality. ReleasedAugust 25, 2011. Available at: Accessed September 1, 2011. http://www.iom.edu/vaccineadverseeffects.
39. Lovaas O.I. Behavioral treatment and normal educational and intellectual functioning in young autistic children. JConsult Clin Psychol 1987, 55:3-9.
40. Sallows G.O., Graupner T.D. Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am J Ment Retard 2005, 110:417-438.
41. Ospina M.B., Krebs S.J., Clark B., et al. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One 2008, 3:e3755.
42. Wakefield A.J., Murch S.H., Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351:637-641.
43. Black C., Kaye J.A., Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ 2002, 325:419-421.
44. Andrew Wakefield. Wikipedia, the free encyclopedia. Available at: Accessed September 1, 2011. http://en.wikipedia.org/wiki/Andrew_Wakefield.
45. Godlee F., Smith J., Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ 2011, 342:c7452.
46. Eggertson L. Lancet retracts 12-year-old article linking autism to MMR vaccines. CMAJ 2010, 182:E199-E200.
47. Institute of Medicine, Immunizaition Safety Review Committee Immunization safety review: vaccines and autism 2004, National Academies Press, Washington, DC.
48. Gerber J.S., Offit P.A. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis 2009, 48:456-461.
49. Offit P.A. Autism's false prophets: bad science, risky medicine, and the search for a cure 2008, Columbia University Press, Columbia (NY), p. 296.
50. Rapin I. High hopes, shoddy research, and elusive therapies for autism examined and exposed. Neurology Today 2009, 9:23.
51. Adashi EY, Offit PA. Paul Offit on the dangers of the anti-vaccine movement. Available at: Accessed October 24, 2011. http://www.medscape.com/viewarticle/741343?src=mp&spon=24.
52. Paul Offit. Wikipedia. Available at: Accessed September 1, 2011. http://en.wikipedia.org/wiki/Paul_Offit.
53. Baker J.P. Autism in 1959: Joey the mechanical boy. Pediatrics 2010, 125:1101-1103.
54. Rapin I.E. Autism: where we have been, where are we going?. Handbook of autism and pervasive developmental disorders 2005, vol. 2:1304-1317. Assessment, interventions, and policy, John Wiley, New York, Chapter 53. 3rd edition. F.R. Volkmar, R. Paul, A. Klin (Eds.).
55. Speers T., Lewis J. Journalists and jabs: media coverage of the MMR vaccine. Commun Med 2004, 1:171-181.
56. Brugha T.S., McManus S., Bankart J., et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 2011, 68:459-466.
57. Heidgerken A.D., Geffken G., Modi A., et al. Asurvey of autism knowledge in a health care setting. JAutism Dev Disord 2005, 35:323-330.
58. World Health Organization International classification of diseases: diagnostic criteria for research 1992, World Health Organization, Geneva (Switzerland). 10th edition.
59. Freed G.L., Clark S.J., Butchart A.T., et al. Parental vaccine safety concerns in 2009. Pediatrics 2010, 125:654-659.
60. Goodman N.W. MMR scare stories: some things are just too attractive to the media. BMJ 2007, 335:222.
61. Greydanus D.E., Patel D.R., Feucht C. Preface: pediatric and adolescent psychopharmacology: the past, the present, and the future. Pediatr Clin N Am 2011, 58:xv-xxiv.
62. Chatterjee A., O'Keefe C. Current controversies in the USA regarding vaccine safety. Expert Rev Vaccines 2010, 9:497-502.
63. Sugarman S.D. Cases in vaccine court-legal battles over vaccines and autism. NEngl J Med 2007, 357:1275-1277.
64. Artigas-Pallarés J. Rev Neurol 2010, 3(50 Suppl 3):S91-S99. [in Spanish].
65. Bragesiö F., Haliberg M. Dilemmas of a vitalizing vaccine market: lesions from the MMR vaccine/autism debate. Sci Context 2011, 24:107-125.
66. Ratajczak H.V. Theoretical aspects of autism-a review. JImmunotoxicol 2011, 8:68-79.